97 related articles for article (PubMed ID: 2056259)
1. Treatment of community-acquired pneumonia with ofloxacin.
Youngchaiyud P; Permpikul C; Thamlikitkul V; Charoenratanakul S; Nana A
J Med Assoc Thai; 1991 Feb; 74(2):61-5. PubMed ID: 2056259
[TBL] [Abstract][Full Text] [Related]
2. [The combination of penicillin G and ofloxacin: a response to the empirical treatment of community acquired pneumonia].
Dopff C; Mertes PM; Nace L; Gerard A; Voiriot P; Preiss MA; May T; Canton P; Dureux JB
Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):526-9. PubMed ID: 2385449
[TBL] [Abstract][Full Text] [Related]
3. Parenteral followed by oral ofloxacin for nosocomial pneumonia and community-acquired pneumonia requiring hospitalization.
Gentry LO; Rodriguez-Gomez G; Kohler RB; Khan FA; Rytel MW
Am Rev Respir Dis; 1992 Jan; 145(1):31-5. PubMed ID: 1731595
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of ofloxacin taken orally in 19 severe infections.
Potel G; Touze MD; Reynaud A; Courtieu AL; Baron D
J Chemother; 1989 Jul; 1(4 Suppl):679-81. PubMed ID: 16312590
[No Abstract] [Full Text] [Related]
5. Ofloxacin in community-acquired lower respiratory infections. A comparison with amoxicillin or erythromycin.
Stocks JM; Wallace RJ; Griffith DE; Garcia JG; Kohler RB
Am J Med; 1989 Dec; 87(6C):52S-56S. PubMed ID: 2690620
[TBL] [Abstract][Full Text] [Related]
6. Oral levofloxacin in the treatment of community-acquired pneumonia.
Nicodemo AC; Lima Nicodemo E; Idrahim KY
Braz J Infect Dis; 2000 Apr; 4(2):61-6. PubMed ID: 10795070
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the usefulness of sputum culture for diagnosis of community-acquired pneumonia using the PORT predictive scoring system.
García-Vázquez E; Marcos MA; Mensa J; de Roux A; Puig J; Font C; Francisco G; Torres A
Arch Intern Med; 2004 Sep; 164(16):1807-11. PubMed ID: 15364677
[TBL] [Abstract][Full Text] [Related]
8. Intravenous followed by oral ofloxacin in the treatment of community acquired lower respiratory tract infections in adults requiring hospitalisation.
Liam CK; Aziah AM; Lim KH; Wong CM
Med J Malaysia; 2000 Sep; 55(3):304-7. PubMed ID: 11200708
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia.
Bradley JS; Arguedas A; Blumer JL; Sáez-Llorens X; Melkote R; Noel GJ
Pediatr Infect Dis J; 2007 Oct; 26(10):868-78. PubMed ID: 17901791
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin.
Bergallo C; Jasovich A; Teglia O; Oliva ME; Lentnek A; de Wouters L; Zlocowski JC; Dukart G; Cooper A; Mallick R;
Diagn Microbiol Infect Dis; 2009 Jan; 63(1):52-61. PubMed ID: 18990531
[TBL] [Abstract][Full Text] [Related]
11. High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm.
Dunbar LM; Wunderink RG; Habib MP; Smith LG; Tennenberg AM; Khashab MM; Wiesinger BA; Xiang JX; Zadeikis N; Kahn JB
Clin Infect Dis; 2003 Sep; 37(6):752-60. PubMed ID: 12955634
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and treatment of community-acquired and hospital-acquired pneumonia.
Foster MT
Pharmacotherapy; 1993; 13(2 Pt 2):45S-50S. PubMed ID: 8474938
[TBL] [Abstract][Full Text] [Related]
13. Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial.
Torres A; Garau J; Arvis P; Carlet J; Choudhri S; Kureishi A; Le Berre MA; Lode H; Winter J; Read RC;
Clin Infect Dis; 2008 May; 46(10):1499-509. PubMed ID: 18419482
[TBL] [Abstract][Full Text] [Related]
14. Clinical experience with parenteral and oral ofloxacin in severe infections.
Kanellakopoulou K; Giamarellou H
Scand J Infect Dis Suppl; 1990; 68():64-9. PubMed ID: 2218425
[TBL] [Abstract][Full Text] [Related]
15. Oral ofloxacin for the treatment of acute bacterial pneumonia: use of a nontraditional protocol to compare experimental therapy with "usual care" in a multicenter clinical trial.
Sanders WE; Morris JF; Alessi P; Makris AT; McCloskey RV; Trenholme GM; Iannini P; Bittner MJ
Am J Med; 1991 Sep; 91(3):261-6. PubMed ID: 1892146
[TBL] [Abstract][Full Text] [Related]
16. Expectorated sputum for community-acquired pneumonia: a sacred cow.
Madison JM; Irwin RS
Arch Intern Med; 2004 Sep; 164(16):1725-7. PubMed ID: 15364664
[No Abstract] [Full Text] [Related]
17. Treating community-acquired lower respiratory infection.
Meyers BR
Am Fam Physician; 1983 Sep; 28(3):204-10. PubMed ID: 6351571
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the effectiveness of ofloxacin in the treatment of respiratory tract].
Chyrek-Borowska S; Siergiejko Z; Jakubicz P
Pneumonol Alergol Pol; 1991; 59(1-2):22-7. PubMed ID: 1843882
[TBL] [Abstract][Full Text] [Related]
19. Oral ofloxacin as treatment of malignant external otitis: a study of 17 cases.
Levy R; Shpitzer T; Shvero J; Pitlik SD
Laryngoscope; 1990 May; 100(5):548-51. PubMed ID: 2109817
[TBL] [Abstract][Full Text] [Related]
20. Levofloxacin for the treatment of community-acquired pneumonia.
Lynch JP; File TM; Zhanel GG
Expert Rev Anti Infect Ther; 2006 Oct; 4(5):725-42. PubMed ID: 17140350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
